Abstract

BackgroundAlterations in the gut microbiota after ischemic stroke have been demonstrated, whereas the effect on stroke outcome remains to be established.MethodsA total of 132 consecutive patients with acute ischemic stroke were prospectively enrolled. Their gut microbiomes within 24 h of admission were profiled using 16S ribosomal RNA (rRNA) gene (V3–V4 region) sequencing. Microbiota comparisons were made between groups with good outcome (n = 105) and poor outcome (n = 27) based on 3-month modified Rankin Scale scores of 0–2 and 3–6. Propensity score-matching (PSM) analysis was conducted to assess the robustness of our findings. The functional potential was predicted using the Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt).ResultsPatients in the poor outcome group were characterized by a significant reduction in the alpha diversity (Shannon index, p = 0.025; Simpson index, p = 0.010), an increase in the pathogenic bacteria (e.g., Enterococcaceae and Enterococcus), and a decrease in the short-chain fatty acids (SCFAs)-producing bacteria (e.g., Bacteroidaceae, Ruminococcaceae, and Faecalibacterium) to those with good outcome group (all p < 0.05). Similar results of microbial composition were obtained after PSM. The PICRUSt revealed that the pathway for membrane transport was relatively dominant in patients with poor outcome (p < 0.05).ConclusionThis study demonstrated that stroke patients with 3-month poor outcome had baseline gut microbiota dysbiosis featured by increased pathogenic bacteria and decreased SCFAs-producing bacteria.

Highlights

  • Stroke is one of the leading causes of disability and death, especially in the population aged 50 years and older [1]

  • Patients in the poor outcome group had a higher incidence of hypertension and atrial fibrillation, higher baseline National Institutes of Health Stroke Scale (NIHSS) scores, and lower DWIASPECT scores (p < 0.05)

  • We found baseline dysbiosis of gut microbiota in patients with acute ischemic stroke with 3-month unfavorable outcome, featured by decreased alpha diversity, increased opportunistic pathogens (e.g., Enterococcaceae and Enterococcus), and decreased short-chain fatty acids (SCFAs)-producing bacteria (e.g., Bacteroidaceae, Ruminococcaceae, and Faecalibacterium) compared to those in the favorable outcome group

Read more

Summary

Introduction

Stroke is one of the leading causes of disability and death, especially in the population aged 50 years and older [1]. About one-third of patients die or become disabled within the first 3 months [2]. Evidence is emerging that the gut microbiota is intimately involved in the pathology of a wide range of neurological disorders, including acute ischemic stroke [3]. This is supported by the observations that gut microbiota correlates closely with stroke risk factors, such as age, obesity, hypertension, diabetes, dyslipidemia, and atrial fibrillation [4,5,6,7,8]. Alterations in the gut microbiota after ischemic stroke have been demonstrated, whereas the effect on stroke outcome remains to be established

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call